AG003VFS

3737-09-5 | α-Diisopropylaminoethyl-α-phenylpyridine-2-acetamide

AG003VFS

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	3737-09-5
Catalog Number	AG003VFS(AGN-PC-0RDTBN)
Chemical Name	α-Diisopropylaminoethyl-α-phenylpyridine-2-acetamide
EC Number	223-110-2
IUPAC Name	4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide
InChI	InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)
InChI Key	UVTNFZQICZKOEM-UHFFFAOYSA-N
MDL Number	MFCD00057366
Molecular Formula	C21H29N3O
Molecular Weight	339.4745
SMILES	C(C)(C)N(CCC(C(=O)N)(C1=NC=CC=C1)C1=CC=CC=C1)C(C)C
Synonyms	Diisopyramide, Disopyramide, Disopyramide Monohydrochloride, Disopyramide Phosphate, Disopyramide Phosphate (1:1), Disopyramide Phosphate (1:1), (+-)-Isomer, Disopyramide Phosphate (1:1), (R)-Isomer, Disopyramide Phosphate (1:1), (S)-Isomer, Disopyramide, (+-)-Isomer, Disopyramide, (R)-Isomer, Disopyramide, (S)-Isomer, Disopyramide, D-Tartrate (1:1), (S)-Isomer, Disopyramide, L-Tartrate (1:1), (R)-Isomer, Disopyramide, L-Tartrate (1:1), (S)-Isomer, Disopyramide, L-Tartrate (1:2), (+-)-Isomer, Disopyramide, L-Tartrate, (S)-isomer, Norpace, Palpitin, Palpitine, Rhythmodan, Ritmilen, Rythmilen, SC 13957, SC-13957, SC13957, disopyramide, 3737-09-5, Dicorantil, Rythmodan, Disopiramida, Ritmodan, Disopyramidum, Searle 703, Isorythm, Lispine, Disopyramidum [INN-Latin], Disopiramida [INN-Spanish], Disopyramide Free Base, SC 7031, SC-7031, gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide, alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide, H 3292, CHEMBL517, alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide, CHEBI:4657, UVTNFZQICZKOEM-UHFFFAOYSA-N, EINECS 223-110-2, MFCD00057366, 4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide, NCGC00015358-18, 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide, 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, DSSTox_CID_25536, DSSTox_RID_80938, DSSTox_GSID_45536, 4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide, xi-Disopyramide, 4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide, Rythmodan-La, 2-Pyridineacetamide, alpha-(2-(diisopropylamino)ethyl)-alpha-phenyl-, Rythmodan P, 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-, CAS-3737-09-5, Rythmodan P (TN), 54687-36-4, SR-01000003039, NCGC00016985-01, Prestwick_681, Disopyramide [USAN:BAN:INN:JAN], Lispine|||Ritmilen, Norpace (Salt/Mix), Spectrum_001008, Prestwick0_000266, Prestwick1_000266, Prestwick2_000266, Prestwick3_000266, Spectrum2_001033, Spectrum3_000404, Spectrum4_000524, Spectrum5_000943, D 7644, Lopac0_000402, Lopac0_000411, SCHEMBL16153, BSPBio_000112, BSPBio_001928, KBioGR_001127, KBioSS_001488, MLS002222242, DivK1c_000489, SPBio_001245, SPBio_002331, AC1L1F78, BPBio1_000124, GTPL7167, SC 13957 (Salt/Mix), DTXSID1045536, CTK1H1096, KBio1_000489, KBio2_001488, KBio2_004056, KBio2_006624, KBio3_001148, Disopyramide (JP17/USAN/INN), NINDS_000489, HMS1568F14, HMS2095F14, HMS2234G08, HMS3261A06, HMS3369O21, HMS3712F14, Disopyramide [USAN:INN:BAN:JAN], Disopyramide 1.0 mg/ml in Methanol, Tox21_110727, Tox21_500402, BDBM50028893, AKOS015894712, alpha-[2-[Bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridine acetamide, Tox21_110727_1, CCG-204495, DB00280, LP00402, MCULE-8866988334, IDI1_000489, NCGC00015358-04, NCGC00015358-05, NCGC00015358-06, NCGC00015358-08, NCGC00015358-09, NCGC00015358-10, NCGC00015358-11, NCGC00015358-12, NCGC00015358-13, NCGC00015358-14, NCGC00015358-15, NCGC00015358-19, NCGC00093829-01, NCGC00093829-02, NCGC00093829-03, NCGC00261087-01, AC-16018, AK688967, SMR001307254, SBI-0050388.P005, LS-185086, AB00053462, D2793, EU-0100402, FT-0667714, ST50411970, Y5028, C06965, D00303, 20509-EP2272972A1, 20509-EP2272973A1, 20509-EP2277872A1, 20509-EP2314585A1, AB00053462_16, AB00053462_17, C-44340, I05-3196, SR-01000003039-3, 4-Diisopropylamino-2-phenyl-2-(2-pyridyl)-butyramide, BRD-A29734509-001-03-8, BRD-A29734509-011-02-9, BRD-A29734509-011-06-0, SR-01000003039-10, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridinyl)butanamide, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridyl)butyramide, Z2786051711, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridinyl)butanamide #, 4-[bis(methylethyl)amino]-2-phenyl-2-(2-pyridyl)butanamide, Disopyramide, European Pharmacopoeia (EP) Reference Standard, .alpha.-(2-(Diisopropylamino)ethyl)-.alpha.-phenyl-2-pyridineacetamide, .gamma.-Diisopropylamino-.alpha.-phenyl-.alpha.-(2-pyridyl)butyramide, 2-Pyridineacetamide, .alpha.-[2-(diisopropylamino)ethyl]-.alpha.-phenyl-, 4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanimidic acid, racemic 2-phenyl-2-(2-pyridyl)-4-[N,N-bis(1-methylethyl)amino]butanamide, alpha-[2-[Bis(1-methylethyl)amino]ethyl]- alpha-phenyl-2-pyridine acetamide, Norpace, Diisopyramide, Rhythmodan, Degrasyn, Palpitin, Palpitine, Ritmilen, Rythmilen, Triombrin, Hypaque sodium, Norpace Cr, Disopyramide HCl, DISOPYRAMIDE PHOSPHATE, Rythmodan (TN), amidotrizoate sodium, Norpace (TN), disopyramide tartrate, Disopyramide hydrochloride, N-Desalkyl disopyramide, Disopyramide Monohydrochloride, Disopyramide, (R)-Isomer, Disopyramide, (S)-Isomer, D0M4YC, UNII-GFO928U8MQ, GFO928U8MQ, C21H29N3O.ClH, Disopyramide, (+-)-Isomer, 2-(methylmercapto)benzoic acid, Disopyramide Phosphate (1:1), C21H29N3O, CID3114, Disopyramide (JP15/USAN/INN), C21-H29-N3-O.Cl-H, MFCD00029934, SC-13957, Disopyramide, L-Tartrate, (S)-isomer, CS-O-01366, SC13957, SC 13957, Disopyramide Phosphate (1:1), (R)-Isomer, Disopyramide Phosphate (1:1), (S)-Isomer, Disopyramide Phosphate (1:1), (+-)-Isomer, Disopyramide, D-Tartrate (1:1), (S)-Isomer, Disopyramide, L-Tartrate (1:1), (R)-Isomer, Disopyramide, L-Tartrate (1:1), (S)-Isomer, Disopyramide, L-Tartrate (1:2), (+-)-Isomer, D004206, (S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide, 22059-60-5, alpha-(2-(Bis(1-methylethyl)amino)ethyl)-alpha-phenyl-2-pyridineacetamide hydrochloride, 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, monohydrochloride, 38236-46-3, 856243-80-6, na,

Complexity	409
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	339.231g/mol
Formal Charge	0
Heavy Atom Count	25
Hydrogen Bond Acceptor Count	3
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	339.483g/mol
Monoisotopic Mass	339.231g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	59.2A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	3.2

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H302-H361
Packing Group	Ⅲ
Precautionary statements	P280-P301+P312+P330
UN Code	UN 2811

Certificate of Analysis

Lot Number